Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 13 Oct 2021, 15:45 ASCENDIS HEALTH LIMITED - Cautionary Announcement
Cautionary Announcement

 Ascendis Health Limited
 (Registration number 2008/005856/06)
 (Incorporated in the Republic of South Africa)
 Share code: ASC
 ISIN: ZAE000185005
 (“Ascendis Health” or “the Company”)


                                        CAUTIONARY ANNOUNCEMENT


Shareholders are advised that the Company has commenced the process regarding the potential disposal of its
business segment known as “Ascendis Pharma”, which, if successfully concluded, may have a material effect on
the price at which the Company’s shares trade.

Accordingly, shareholders are advised to exercise caution when dealing in their Ascendis Health shares until a
further announcement is made.


13 October 2021
Bryanston

Sponsor

Questco Corporate Advisory Proprietary Limited




                                                                                                            1

Date: 13-10-2021 03:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData


Follow us on: